The Cooper Companies, Inc. Common Stock (COO) Stock Analysis
Price: $66.71 · -1.46% · Sector: Healthcare · Industry: Ophthalmic Goods
Company Overview
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Headquarters: SAN RAMON, CA · Employees: 15,000 · Website ↗
Financial Health Scores
- Health Score
- 74/100
- moderate
- Profitability
- 55/100
- moderate
- Valuation Score
- 90/100
- strong
- Piotroski F-Score
- 6/9
- Altman Z-Score
- 3.08
- Safe zone
- Revenue CAGR
- 8.78%
- Net Income CAGR
- -40.27%
- FCF Margin
- 13.46%
- Debt Repayment
- 4.1 yrs
- Margin Stability
- 2.68%
Neutral
Analyst Consensus
BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 9, 2026
Recent Market Moves
See all COO moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 25 | Regular | 73.34 | -3.25% | -2.16 |
| Aug 25 | After-hours | 73.04 | -3.64% | -2.43 |
PMP Score
Coming soonA point-in-time composite score ranking future winners — built on the same data you see above.
- Earnings35%
- Awaiting PIT data
- Fundamentals30%
- Live — see scores above
- Momentum25%
- Awaiting PIT data
- Quality10%
- Awaiting PIT data
The earnings pillar requires timestamped analyst-consensus history (point-in-time verified) — currently in vendor procurement. No score is published until the data passes the PIT integrity gate.